C57BL/6-Ccr2tm1(cre/ERT2,mKate2)Arte/Orl

Status

Available to order

EMMA IDEM:12698
International strain nameC57BL/6-Ccr2tm1(cre/ERT2,mKate2)Arte/Orl
Alternative nameC57BL/6NTac-Ccr2tm2982(T2A-Cre/ESR1-T2A-mKate2)Art
Strain typeTargeted Mutant Strains
Allele/Transgene symbolCcr2tm1(cre/ERT2,mKate2)Arte
Gene/Transgene symbolCcr2

Information from provider

ProviderBurkhard Becher
Provider affiliationUniversity of Zurich
Genetic informationCcr2-CreERT2-mKate2: This strain contains the ORF of CreERT2 and mKate2 knocked into the endogenous murine Ccr2 locus. Ensembl gene ID: ENSMUSG00000049103
Phenotypic informationHomozygous:
Animals are viable and fertile, no phenotypic difference to C57BL/6 mice.

Heterozygous:
Animals are viable and fertile, no phenotypic difference to C57BL/6 mice.
Breeding historyThe mice have been bred in our facility for many generations and more than 100 animals were born. Heterozygous and homozygous mice are viable and fertile.
References
  • The Cytokine GM-CSF Drives the Inflammatory Signature of CCR2+ Monocytes and Licenses Autoimmunity.;Croxford Andrew L, Lanzinger Margit, Hartmann Felix J, Schreiner Bettina, Mair Florian, Pelczar Pawel, Clausen Björn E, Jung Steffen, Greter Melanie, Becher Burkhard, ;2015;Immunity;43;502-14; 26341401
Homozygous fertileyes
Homozygous viableyes
Homozygous matings requiredno
Immunocompromisedno

Information from EMMA

Archiving centreInstitut de Transgenose, INTRAGENE, Orléans, France
Animals used for archivingheterozygous C57BL/6NTac

Disease and phenotype information

IMPC phenotypes (gene matching)
  • decreased lymphocyte cell number / IMPC
  • abnormal heart left ventricle morphology / IMPC
  • decreased monocyte cell number / IMPC
  • increased eosinophil cell number / IMPC
  • increased cardiac muscle contractility / IMPC
  • enlarged heart / IMPC
  • abnormal gait / IMPC
  • decreased neutrophil cell number / IMPC
MGI phenotypes (gene matching)
  • abnormal trabecular bone morphology / MGI
  • decreased neutrophil cell number / MGI
  • decreased monocyte cell number / MGI
  • altered response to myocardial infarction / MGI
  • enlarged liver / MGI
  • abnormal spleen morphology / MGI
  • enlarged spleen / MGI
  • weight loss / MGI
  • retinal degeneration / MGI
  • abnormal osteoclast physiology / MGI
  • hepatic necrosis / MGI
  • multifocal hepatic necrosis / MGI
  • liver inflammation / MGI
  • decreased inflammatory response / MGI
  • abnormal glucose homeostasis / MGI
  • abnormal lipid homeostasis / MGI
  • decreased airway responsiveness / MGI
  • increased susceptibility to bacterial infection / MGI
  • increased susceptibility to viral infection / MGI
  • abnormal leukocyte physiology / MGI
  • abnormal macrophage morphology / MGI
  • increased IgG level / MGI
  • alcohol aversion / MGI
  • abnormal monocyte morphology / MGI
  • abnormal immune serum protein physiology / MGI
  • abnormal conditioned taste aversion behavior / MGI
  • increased circulating alanine transaminase level / MGI
  • abnormal cytokine secretion / MGI
  • no phenotypic analysis / MGI
  • abnormal leukocyte migration / MGI
  • decreased tumor growth/size / MGI
  • increased alcohol consumption / MGI
  • decreased alcohol consumption / MGI
  • abnormal leukocyte adhesion / MGI
  • abnormal microglial cell physiology / MGI
  • impaired macrophage chemotaxis / MGI
  • decreased macrophage cell number / MGI
  • increased hepatocyte apoptosis / MGI
  • liver hemorrhage / MGI
  • decreased susceptibility to kidney reperfusion injury / MGI
  • decreased susceptibility to experimental autoimmune encephalomyelitis / MGI
  • abnormal vascular wound healing / MGI
  • abnormal osteoclast cell number / MGI
  • decreased osteoclast cell number / MGI
  • increased eosinophil cell number / MGI
  • increased B cell number / MGI
  • abnormal wound healing / MGI
  • diarrhea / MGI
  • decreased acute inflammation / MGI
  • decreased T cell proliferation / MGI
  • abnormal optic choroid morphology / MGI
  • abnormal retinal pigment epithelium morphology / MGI
  • abnormal Bruch membrane morphology / MGI
  • abnormal cholesterol homeostasis / MGI
  • abnormal renal glomerulus morphology / MGI
  • abnormal podocyte morphology / MGI
  • abnormal Langerhans cell physiology / MGI
  • immune system phenotype / MGI
  • choroidal neovascularization / MGI
  • decreased circulating creatinine level / MGI
  • decreased susceptibility to type I hypersensitivity reaction / MGI
  • retinal deposits / MGI
  • abnormal choriocapillaris morphology / MGI
  • abnormal urine protein level / MGI
  • decreased CD4-positive, alpha beta T cell number / MGI
  • increased CD8-positive, alpha-beta T cell number / MGI
  • increased dendritic cell number / MGI
  • abnormal osteoclast differentiation / MGI
  • retinal photoreceptor degeneration / MGI
  • retinal outer nuclear layer degeneration / MGI
  • increased susceptibility to induced colitis / MGI
  • decreased susceptibility to induced colitis / MGI
  • increased tumor necrosis factor secretion / MGI
  • increased interferon-gamma secretion / MGI
  • decreased interferon-gamma secretion / MGI
  • decreased interleukin-2 secretion / MGI
  • decreased interleukin-6 secretion / MGI
  • abnormal chemokine secretion / MGI
  • decreased common myeloid progenitor cell number / MGI
  • lipofuscinosis / MGI
  • increased physiological sensitivity to xenobiotic / MGI
  • decreased splenocyte proliferation / MGI
  • increased trabecular bone thickness / MGI
  • increased susceptibility to viral infection induced morbidity/mortality / MGI
  • abnormal cellular extravasation / MGI
  • decreased susceptibility to bone fracture / MGI
  • abnormal bone mineral density / MGI
  • abnormal dendritic cell chemotaxis / MGI
  • abnormal macrophage chemotaxis / MGI
  • abnormal bone trabecula morphology / MGI
  • increased trabecular bone volume / MGI
  • increased fluid intake / MGI
  • increased CD11b-high dendritic cell number / MGI
  • decreased CD11b-high dendritic cell number / MGI
  • impaired leukocyte tethering or rolling / MGI

Literature references

  • The Cytokine GM-CSF Drives the Inflammatory Signature of CCR2+ Monocytes and Licenses Autoimmunity.;Croxford Andrew L, Lanzinger Margit, Hartmann Felix J, Schreiner Bettina, Mair Florian, Pelczar Pawel, Clausen Björn E, Jung Steffen, Greter Melanie, Becher Burkhard, ;2015;Immunity;43;502-14; 26341401

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen sperm. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
Distribution of this strain is subject to a provider MTA. Both signing of the MTA and submission of the online EMMA Mutant Request Form are required before material can be shipped.

EMMA conditions
Legally binding conditions for the transfer

Other EMMA strains

Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).